Johan M. Van Den Bergh

Antwerpen, VLG, Belgium

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 21 publications

Lack of functional TCR-epitope interaction is associated with herpes zoster through reduced downstream T cell activation.

Lack of functional TCR-epitope interaction is associated with herpes zoster through reduced downstream T cell activation.

Journal: Cell reports

Published: February 17, 2023

Efficient and Non-genotoxic RNA-Based Engineering of Human T Cells Using Tumor-Specific T Cell Receptors With Minimal TCR Mispairing.

Efficient and Non-genotoxic RNA-Based Engineering of Human T Cells Using Tumor-Specific T Cell Receptors With Minimal TCR Mispairing.

Journal: Frontiers in immunology

Published: June 04, 2018

A versatile T cell-based assay to assess therapeutic antigen-specific PD-1-targeted approaches.

A versatile T cell-based assay to assess therapeutic antigen-specific PD-1-targeted approaches.

Journal: Oncotarget

Published: January 16, 2018

Dendritic Cells and Programmed Death-1 Blockade: A Joint Venture to Combat Cancer.

Dendritic Cells and Programmed Death-1 Blockade: A Joint Venture to Combat Cancer.

Journal: Frontiers in immunology

Published: January 15, 2018

Increased herpes zoster risk associated with poor HLA-A immediate early 62 protein (IE62) affinity.

Increased herpes zoster risk associated with poor HLA-A immediate early 62 protein (IE62) affinity.

Journal: Immunogenetics

Published: October 03, 2017

Shuttling Tolerogenic Dendritic Cells across the Blood-Brain Barrier In Vitro via the Introduction of De Novo C-C Chemokine Receptor 5 Expression Using Messenger RNA Electroporation.

Shuttling Tolerogenic Dendritic Cells across the Blood-Brain Barrier In Vitro via the Introduction of De Novo C-C Chemokine Receptor 5 Expression Using Messenger RNA Electroporation.

Journal: Frontiers in immunology

Published: July 07, 2017

Poly(I:C) primes primary human glioblastoma cells for an immune response invigorated by PD-L1 blockade.

Poly(I:C) primes primary human glioblastoma cells for an immune response invigorated by PD-L1 blockade.

Journal: Oncoimmunology

Published: June 30, 2017

Interleukin-15 stimulates natural killer cell-mediated killing of both human pancreatic cancer and stellate cells.

Interleukin-15 stimulates natural killer cell-mediated killing of both human pancreatic cancer and stellate cells.

Journal: Oncotarget

Published: March 14, 2017

Production of Monosugars from Lignocellulosic Biomass in Molten Salt Hydrates: Process Design and Techno-Economic Analysis.

Production of Monosugars from Lignocellulosic Biomass in Molten Salt Hydrates: Process Design and Techno-Economic Analysis.

Journal: Industrial & engineering chemistry research

Published: March 10, 2017

Monocyte-Derived Dendritic Cells with Silenced PD-1 Ligands and Transpresenting Interleukin-15 Stimulate Strong Tumor-Reactive T-cell Expansion.

Monocyte-Derived Dendritic Cells with Silenced PD-1 Ligands and Transpresenting Interleukin-15 Stimulate Strong Tumor-Reactive T-cell Expansion.

Journal: Cancer immunology research

Published: November 22, 2016

IL-15 receptor alpha as the magic wand to boost the success of IL-15 antitumor therapies: The upswing of IL-15 transpresentation.

IL-15 receptor alpha as the magic wand to boost the success of IL-15 antitumor therapies: The upswing of IL-15 transpresentation.

Journal: Pharmacology & therapeutics

Published: November 05, 2016

Interleukin-15 enhances the proliferation, stimulatory phenotype, and antitumor effector functions of human gamma delta T cells.

Interleukin-15 enhances the proliferation, stimulatory phenotype, and antitumor effector functions of human gamma delta T cells.

Journal: Journal of hematology & oncology

Published: August 10, 2016

Showing 1-12 of 21

Last Updated: 09/26/2026